Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Vaxart begins phase I trial of oral norovirus tablet vaccine

Aug. 5, 2016

Katholieke Universiteit Leuven and Ortho-McNeil-Janssen Pharmaceuticals present antiviral compounds

Aug. 5, 2016

University of Dundee reports compounds to treat leishmaniasis

Aug. 5, 2016

Tribendimidine shows promise for the treatment of O. viverrini infections

Aug. 5, 2016

NIH begins phase I clinical testing of investigational Zika vaccine

Aug. 5, 2016

Inovio continues to independently develop INO-1800 for the treatment of hepatitis B

Aug. 4, 2016

CDC Zika MAC-ELISA test now available to commercial laboratories

Aug. 3, 2016

Human commensals found to produce a novel antibiotic

Aug. 3, 2016

BARDA awards contract to Altimmune for anthrax vaccine candidate

Aug. 3, 2016

ContraVir Pharmaceuticals' tenofovir analogue for HBV safe and well tolerated in phase Ib study

Aug. 3, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...